Future Clinical and Economic Impact of Revision Total Hip and Knee Arthroplasty
Steven M. Kurtz, PhD Kevin L. Ong, PhD Jordana Schmier, MA Fionna Mowat, PhD Khaled Saleh, MD, MSc, FRSCS Eva Dybvik, MSc Johan Kärrholm, MD, PhD Göran Garellick, MD, PhD Leif I. Havelin, MD, PhD Ove Furnes, MD, PhD Henrik Malchau, MD, PhD Edmund Lau, MSHip Knee
A recent analysis of historical procedure data indicated that the prevalence of primary and revision total hip and total knee arthroplasty increased steadily between 1990 and 20021. A massive demand for primary and revision surgeries is also expected in the next two decades2. Similarly, the overall incidence of deep infection also has increased substantially between 1990 and 2003 for both total hip arthroplasty and total knee arthroplasty3. In 2003, approximately 1.2% of the total hip arthroplasties performed in the United States were associated with deep infection, which was similar to the rate seen for total knee arthroplasties3. Deep infection is a catastrophic complication of both total hip and total knee arthroplasty, and it also represents a tremendous economic burden4,5. The implications for a growing incidence of infections, coupled with accelerating demand for arthroplasty, remain unexplored.
Link to article